Alafi Capital Co Llc - Net Worth and Insider Trading
Alafi Capital Co Llc Net Worth
The estimated net worth of Alafi Capital Co Llc is at least $259 Million dollars as of 2024-05-09. Alafi Capital Co Llc is the 10% Owner of Intra-Cellular Therapies Inc and owns about 3,953,270 shares of Intra-Cellular Therapies Inc (ITCI) stock worth over $259 Million. Details can be seen in Alafi Capital Co Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Alafi Capital Co Llc has not made any transactions after 2017-10-02 and currently still holds the listed stock(s).
Transaction Summary of Alafi Capital Co Llc
Alafi Capital Co Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Alafi Capital Co Llc owns 2 companies in total, including Intra-Cellular Therapies Inc (ITCI) , and Stereotaxis Inc (STXS) .
Click here to see the complete history of Alafi Capital Co Llc’s form 4 insider trades.
Insider Ownership Summary of Alafi Capital Co Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ITCI | Intra-Cellular Therapies Inc | 2017-10-02 | 10 percent owner |
| STXS | Stereotaxis Inc | 2004-08-11 | 10 percent owner |
Alafi Capital Co Llc Latest Holdings Summary
Alafi Capital Co Llc currently owns a total of 1 stock. Alafi Capital Co Llc owns 3,953,270 shares of Intra-Cellular Therapies Inc (ITCI) as of October 2, 2017, with a value of $259 Million.
Latest Holdings of Alafi Capital Co Llc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ITCI | Intra-Cellular Therapies Inc | 2017-10-02 | 3,953,270 | 65.56 | 259,176,381 |
Holding Weightings of Alafi Capital Co Llc
Alafi Capital Co Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Alafi Capital Co Llc has made a total of 0 transactions in Intra-Cellular Therapies Inc (ITCI) over the past 5 years. The most-recent trade in Intra-Cellular Therapies Inc is the acquisition of 258,065 shares on October 2, 2017, which cost Alafi Capital Co Llc around $4 Million.
Insider Trading History of Alafi Capital Co Llc
- 1
Alafi Capital Co Llc Trading Performance
GuruFocus tracks the stock performance after each of Alafi Capital Co Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Alafi Capital Co Llc is -7.52%. GuruFocus also compares Alafi Capital Co Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Alafi Capital Co Llc within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Alafi Capital Co Llc's insider trading performs compared to the benchmark.
Performance of Alafi Capital Co Llc
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.65 | | | | | |
| Relative Return to S&P 500(%) | -0.92 | | | | | |
Alafi Capital Co Llc Ownership Network
Alafi Capital Co Llc Owned Company Details
What does Intra-Cellular Therapies Inc do?
Who are the key executives at Intra-Cellular Therapies Inc?
Alafi Capital Co Llc is the 10 percent owner of Intra-Cellular Therapies Inc. Other key executives at Intra-Cellular Therapies Inc include Chief Medical Officer Suresh K. Durgam , EVP & Chief Commercial Officer Mark Neumann , and VP of Finance & CFO & Secretary Lawrence J. Hineline .
Intra-Cellular Therapies Inc (ITCI) Insider Trades Summary
Over the past 18 months, Alafi Capital Co Llc made no insider transaction in Intra-Cellular Therapies Inc (ITCI). Other recent insider transactions involving Intra-Cellular Therapies Inc (ITCI) include a net sale of 181,034 shares made by Mark Neumann , a net sale of 554,970 shares made by Sharon Mates , and a net sale of 233,341 shares made by Michael Halstead .
In summary, during the past 3 months, insiders sold 237,827 shares of Intra-Cellular Therapies Inc (ITCI) in total and bought 0 shares, with a net sale of 237,827 shares. During the past 18 months, 1,382,842 shares of Intra-Cellular Therapies Inc (ITCI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,382,842 shares.
Intra-Cellular Therapies Inc (ITCI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Intra-Cellular Therapies Inc Insider Transactions
Alafi Capital Co Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Alafi Capital Co Llc. You might contact Alafi Capital Co Llc via mailing address: Po Box 7338, Berkeley Ca 94707.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
